Cargando…
Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen Signaling Pathway
There are significant gender differences in the incidence and mortality of hepatocellular carcinoma (HCC). Compared with men, the incidence and mortality of HCC in women are relatively low. The estrogen signaling pathway, composed of estrogen and estrogen receptors, has been postulated to have a pro...
Autores principales: | Guo, Yusheng, Wu, Guohui, Yi, Junrong, Yang, Qin, Jiang, Wengong, Lin, Shaoqiang, Yang, Xiaorong, Cai, Xiangsheng, Mao, Liufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789654/ https://www.ncbi.nlm.nih.gov/pubmed/35096574 http://dx.doi.org/10.3389/fonc.2021.763539 |
Ejemplares similares
-
Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer
por: Liu, Jian, et al.
Publicado: (2021) -
Volatile Anesthetics Regulate Anti-Cancer Relevant Signaling
por: Wang, Jiaqiang, et al.
Publicado: (2021) -
Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets via integrated bioinformatics analysis and experimental validation
por: Chen, Bo, et al.
Publicado: (2022) -
Mediator Complex Subunit 19 Promotes the Development of Hepatocellular Carcinoma by Regulating the AKT/mTOR Signaling Pathway
por: Zhang, Yuting, et al.
Publicado: (2022) -
Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer
por: Li, Yingying, et al.
Publicado: (2022)